our study provides novel insights into the molecular mechanisms underlying the effects of dapagliflozin on DKD.
Identification of circular RNAs and functional competing endogenous RNA networks in human proximal tubular epithelial cells treated with sodium-glucose cotransporter 2 inhibitor dapagliflozin in diabetic kidney disease.